Site #224 — St Louis, Missouri

Site #224 is a clinical research site located in St Louis, Missouri, United States 63125.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site #224 has participated in 1 clinical trials.

Therapeutic areas: Antipsychotic-induced Weight Gain (AIWG).

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #224?

Site #224 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #224 conducted?

Site #224 has 1 clinical trials on record. Their work covers Antipsychotic-induced Weight Gain (AIWG).

Is Site #224 accredited by Crixeo Health?

Site #224 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #224?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.